Diagnosed incident cases of HER2-positive breast cancer to grow at 1.5% AGR between 2023-2033 across 8MM, forecasts GlobalData
The diagnosed incident cases of HER2-positive (HER2+) breast cancer in the eight major markets (*8MM) are projected to increase from 107,352 in 2023 to 123,580...